What is the fair value of Coloplast A (OTC-CLPB.Y) stock?

The current fair value estimate for Coloplast A (OTC-CLPB.Y) is $8.34. This implies an estimated upside of 32.4% versus the current market price.

Is Coloplast A (OTC-CLPB.Y) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 32.4% versus the current market price.

What is the analyst price target for OTC-CLPB.Y stock?

The available analyst price target for Coloplast A (OTC-CLPB.Y) is $8.30. The analyst target implies estimated upside of 31.7%.

How is the financial health of Coloplast A?

The current financial health read for Coloplast A (OTC-CLPB.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Coloplast A's next earnings date?

The next earnings date currently listed for Coloplast A (OTC-CLPB.Y) is August 18, 2026.

Does Coloplast A (OTC-CLPB.Y) pay dividends?

Based on the current data, dividend yield is 1.3%, upcoming dividend amount is 0.22.

What is the P/E ratio for Coloplast A (OTC-CLPB.Y)?

The current P/E ratio listed for Coloplast A (OTC-CLPB.Y) is 44.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Coloplast A?

The current market capitalization listed for Coloplast A is 14.392 B.

What is the enterprise value of Coloplast A?

The current enterprise value listed for Coloplast A is 18.16 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Coloplast A?

The ticker symbol for Coloplast A is OTC-CLPB.Y, and the stock is listed on OTC Markets.

Where is Coloplast A (OTC-CLPB.Y) listed?

Coloplast A (OTC-CLPB.Y) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Coloplast A?

The current debt-to-total-capital ratio listed for Coloplast A is 20.5%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Coloplast A?

The free float listed for Coloplast A is 64.2%. Free float helps investors understand how much of the share base is available for public trading.

Coloplast A (CLPBY) Fair Value & Stock Analysis

Coloplast A (CLPBY)

Coloplast A/S is the issuer associated with this OTC-listed depositary receipt. The underlying business develops and sells intimate healthcare products used in areas such as ostomy care, continence care, voice and respiratory care, interventional urology, and advanced wound dressings and biologics. Its portfolio includes ostomy solutions and accessories, catheter and irrigation products, wound dressings, and devices used in the treatment of urological and gynecological conditions. The company also markets laryngectomy and tracheostomy care products. Coloplast was founded in 1954 and is headquartered in Humlebæk, Denmark, with activities in Denmark, the United States, the United Kingdom, France, and other international markets.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-CLPB.Y	$8.34	32.4% Upside	Undervalued	$8.30	31.7% Upside	Undervalued	Good	—	—	0.22	1.3%	August 18, 2026	44.7x	7.3x	3.4x	14.392 B	18.16 B	20.5%	64.2%	10.2	246.2%	288.3%

Send a message